Refine
Year of publication
- 2015 (2688) (remove)
Document Type
- Article (936)
- Part of Periodical (360)
- Book (333)
- Doctoral Thesis (188)
- Working Paper (179)
- Contribution to a Periodical (174)
- Report (161)
- Review (152)
- Part of a Book (100)
- Preprint (55)
Language
- German (1319)
- English (1256)
- Portuguese (28)
- French (18)
- Spanish (17)
- Croatian (14)
- Multiple languages (13)
- Italian (12)
- Turkish (8)
- Hebrew (1)
Keywords
- Deutsch (52)
- Literatur (47)
- Rezension (38)
- Islamischer Staat (34)
- taxonomy (29)
- IS (25)
- Rezeption (24)
- Terrorismus (23)
- new species (22)
- Deutschland (21)
Institute
- Präsidium (336)
- Medizin (250)
- Gesellschaftswissenschaften (239)
- Physik (184)
- Wirtschaftswissenschaften (148)
- Exzellenzcluster Die Herausbildung normativer Ordnungen (118)
- Center for Financial Studies (CFS) (115)
- Biowissenschaften (102)
- Informatik (96)
- Frankfurt Institute for Advanced Studies (FIAS) (95)
A number of recent studies regress a "narratively" identified measure of a macroeconomic shock directly on an outcome variable. In this note, we argue that this approach can be viewed as the reduced-form regression of an instrumental variable approach in which the narrative time series is used as an instrument for an endogenous series of interest. This motivates evaluating the validity of narrative measures through the lens of a randomized experiment. We apply our framework to four recently constructed narrative measures of tax shocks by Romer and Romer (2010), Cloyne (2013), and Mertens and Ravn (2012). All of them turn out to be weak instruments for observable measures of taxes. After correcting for weak instruments, we find that using any of the considered narrative tax measures as an instrument for cyclically adjusted tax revenues yields tax multiplier estimates that are indistinguishable from zero. We conclude that the literature currently understates the uncertainty associated with quantifying the tax multiplier.
G protein coupled receptors (GPCRs) constitute the largest family of cell-surface receptors in mammals and are key players in signal transduction. By responding to a plethora of extracellular stimuli ranging from photons to amines to fatty acids to peptides and proteins, these receptors trigger intracellular signalling cascades and regulate a variety of cellular responses. Approximately 800 genes in humans encode GPCRs which are classified according to sequence conservation into rhodopsin-like, glutamate, adhesion, frizzled/taste2 and secretin receptors. GPCRs share a seven transmembrane domain fold undergoing a conformational change upon ligand binding which is translated to the intracellular surface of the receptor thereby allowing a heterotrimeric G protein to couple. Heterotrimeric G proteins consist of a Ga, Gb and Gg subunit and dissociate into their Ga and Gbg entities upon activation by a GPCR. Subsequently, distinct signalling cascades are triggered by each G protein protomer.
Membrane proteins and GPCRs in particular, are highly important targets in drug design and development as currently approximately 60% of all marketed drugs target membrane proteins. Although these classes of proteins are of high therapeutic interest, our understanding of their mechanism of action and structure remains limited. The first structure of a human GPCR was determined in 2007 and required the development of protein engineering and innovative crystallisation techniques. Since then, approximately 130 GPCR structures of less than 40 individual receptors have been determined providing insights into the structural arrangement of the transmembrane helices, ligand binding pockets and G protein interactions. Combined with spectroscopic methods, these studies allowed a more detailed understanding of the molecular aspects of GPCR activation and signalling. Despite the tremendous advances in GPCR structural biology, certain aspects of GPCR function still remain poorly understood. Due to their size and inherent flexibility, the interaction of protein and peptide ligands with their receptors remains a challenging aspect in the structural characterisation of GPCRs. Moreover, structural information on subtype selectivity of peptide ligands continues to be scarce. To contribute functional and structural information on the molecular mechanisms of peptide interactions with GPCRs, this thesis focused on characterising receptors from the chemoattractant cluster using radioligand binding assays as well as NMR spectroscopy.
The chemoattractant cluster mainly groups the kinin, angiotensin, anaphylatoxin chemotactic complement and apelin receptors according to conserved residues in their ligand binding cavities. All receptors in this cluster bind to peptide ligands deriving from high molecular weight protein precursors upon proteolytic processing. Comparable to the conserved binding pocket of the chemoattractant receptors, the peptide ligands display a certain sequence conservation although they differ strongly in size. The largest ligands used in this thesis are the anaphylatoxins complement 3a and 5a, comprising 77 or 74 residues, respectively. Due to their size and complex fold involving three intramolecular disulphide bonds, solid phase synthesis is impossible, which prompted us to develop a modified cell-free expression system to produce these ligands in tritiated form for subsequent functional characterisation of the complement receptors. To demonstrate the versatility of the developed system, it was applied to another disulphidebond containing peptide ligand, the 21 amino acid endothelin-1. We describe a reliable and multifaceted tool to generate custom labelled peptide ligands for the structural and functional characterisation of GPCRs. The system allows the production of custom radioligands, peptides labelled for NMR studies or with fluorescent amino acids.
Apart from the modulation of GPCR activity by orthosteric ligands, GPCR signalling has long been described to be regulated by allosteric ligands including peptides, small molecules and ions. In this thesis, the influence of sodium ions on the activity state of the chemoattractant cluster receptors and in particular on the apelin, bradykinin 2 and angiotensin II type 1 receptors was examined. In recent high resolution crystal structures an allosteric sodium ion pocket beneath the orthosteric ligand binding cavity was identified and residues contributing to the coordination of sodium ions are conserved throughout the chemoattractant cluster receptors. This allosteric sodium ion coordinated within the transmembrane domain bundle has been described to negatively influence the affinity of agonists but not of antagonists. It was found that sodium ions have distinct influences on the affinity state as well as the available number of binding sites of the chemoattractant receptors. In case of the apelin and bradykinin 2 receptors, sodium ions drastically reduced the number of available binding sites whereas the affinity of peptide ligands to the bradykinin 2 receptors remained constant and the ligand binding affinities to the apelin receptor were completely abolished. In contrast, the angiotensin II type 1 receptor affinity state towards the endogenous peptide ligand angiotensin II is highly dependent on the presence of sodium ions, whereas binding of the synthetic peptide antagonist Sar1-Ile8-angiotensin II remained unaffected by the sodium ion concentration. As differential effects irrespective of the efficacy class but dependent on the amino acid composition of the applied ligands are observed, it can be concluded that electrostatic interactions between charged residues of the peptide ligands and amino acids on the extracellular surface of the receptors are influenced by sodium ions thereby adding another layer of complexity on GPCR signalling.
To elucidate the structure-function relationship of ligand selectivity between the kinin receptors, the structure of desArg10-kallidin (DAK) bound to the bradykinin 1 receptor was determined using solid state NMR (SSNMR) in the course of this thesis. The kinin peptides DAK and bradykinin bind with high affinity and high selectivity to either the bradykinin 1 or bradykinin 2 receptor, respectively. The binding pockets of the receptors are highly conserved and the two peptide ligands only differ in one amino acid at their N- and C-termini whereas the remaining eight amino acids are fully conserved. DAK adopts a U-shaped structure when bound to the bradykinin 1 receptor which resembles a horse shoe-like conformation. Using 2D TEDOR spectroscopy it could furthermore be demonstrated that positively charged residues at the N-terminal part of the peptide engage in ionic interactions with negatively charged amino acids on the extracellular surface of the bradykinin 1 receptor. In contrast, bradykinin displays a distinct b-turn at the C-terminus and an S-shaped conformation of the N-terminal segment when bound to the bradykinin 2 receptor. By using SSNMR to study the binding mode of DAK on the bradykinin 1 receptor we could determine that subtype selectivity between the kinin receptors is conferred by distinct conformational restraints within the peptide ligands and by the formation of specific ionic interaction between charged residues on the peptide and receptor, respectively.
In brief, this thesis contributes structural and functional data on the binding mechanisms and binding mode of different peptide-ligand GPCRs helping to understand subtype selectivity and allosteric modulation of the chemoattractant cluster receptors. In addition, a versatile cell-free expression system was developed that allows the custom synthesis of isotopically labelled peptides containing disulphide bonds for the functional characterisation of GPCRs.
The ability of hematopoietic stem cells (HSCs) to self-renew is a prerequisite for the establishment of definitive hematopoiesis and life-long blood regeneration. Here, we report the single-stranded DNA-binding transcriptional regulator far upstream element (FUSE)-binding protein 1 (FUBP1) as an essential factor of HSC self-renewal. Functional inactivation of FUBP1 in two different mouse models resulted in embryonic lethal anemia at around E15.5 caused by severely diminished HSCs. Fetal and adult HSCs lacking FUBP1 revealed an HSC-intrinsic defect in their maintenance, expansion, and long-term blood reconstitution, but could differentiate into all hematopoietic lineages. FUBP1-deficient adult HSCs exhibit significant transcriptional changes, including upregulation of the cell-cycle inhibitor p21 and the pro-apoptotic Noxa molecule. These changes caused an increase in generation time and death of HSCs as determined by video-microscopy-based tracking. Our data establish FUBP1 and its recognition of single-stranded genomic DNA as an important element in the transcriptional regulation of HSC self-renewal.
Im Rahmen dieser Arbeit wurden grundlegende Eigenschaften von GEM-Verstärkungsstrukturen untersucht. Dies waren der Einfluss des Alignmenteffektes auf die Reproduzierbarkeit von Messungen, die Elektronenextraktionseffizienz von GEMs im allgemeinen und die Auswirkungen von Druckschwankungen auf die Gasverstärkung. Weiterhin wurden verschiedene vierlagige GEM-Verstärkungssysteme mit einer MP-GEM an erster Stelle in Hinblick auf Ionenrückfluss und Energieauflösung untersucht.
Der Alignmenteffekt ist noch nicht vollkommen verstanden und verlangt weitere Untersuchungen. Was aber definitiv gesagt werden kann ist, dass das Drehen der GEMs um 90° die Reproduzierbarkeit der Messergebnisse sicherstellt.
Die unterschiedlichen Elektronenextraktionseffizienzen der verschiedenen GEM-Typen sind noch unverstanden. Auch wenn die grundsätzliche Zunahme der Extraktion mit zunehmenden Transferfeld verständlich ist, so bleibt vor allem das Verhalten einer LP-GEM in diesem Kontext bis jetzt unerklärlich.
Die Versuche mit einer MP-GEM an erster Stelle einer vierlagigen Verstärkungsstruktur haben sich als keine Verbesserung im Vergleich zu den S-Konfigurationen herausgestellt. Auch wenn manche gefundenen Einstellungen die Kriterien von einem IBF von weniger als 1 % und einem σ(55Fe) von weniger als 12 % gleichzeitig erfüllen, liegen diese Messpunkte so knapp an den definierten Grenzen, dass sie nicht für den Betrieb in der Spurendriftkammer von ALICE geeignet sind. Eine Erkenntnis, die trotzdem gewonnen werden konnte, ist, dass sich das Verhalten von verschiedenen Konfigurationen verstehen lässt. So ist die beste untersuchte Konfiguration die MP-LP-LP-S-Konfiguration gewesen, danach folgte die MP-S-LP-S und als schlechteste hat die MP-S-LP-SP-Konfiguration abgeschnitten. Dies ist genau die gleiche Reihenfolge, wie sie auch bei den S-Konfigurationen auftritt: S-LP-LP-S, dann S-S-LP-S und danach S-S-LP-SP. Ein wichtiger Schritt in einem guten Kompromiss zwischen Ionenrückfluss und σ(55Fe), scheinen zwei LP-GEMs an zweiter und dritter Stelle zu sein und weniger der Lochabstand der letzten GEM.
Die Druckabhängigkeit der Gasverstärkung hat einen großen Einfluss auf die Verstärkung und damit auf die Reproduzierbarkeit von Messungen. Bei einem Höhenunterschied von ca. 400 m ergibt sich eine Änderung der Verstärkung von ca. 35 %. Zusätzlich wird dieser Effekt von lokalen Wetterbedingungen überlagert. Der Einfluss des Luftdruckes kann jedoch mit dem Fit in Abbildung 43 berücksichtigt und damit herausgerechnet werden
The Time Projection Chamber (TPC), a large gaseous detector, is the main particle identification device of the ALICE experiment at the CERN LHC. The desired performance of the TPC defines the requirements for the gas mixture used in the detector. The active volume was filled with either Ne-CO2 (90-10) or Ne-CO2-N2 (90-10-5) during the first LHC running period. For LHC Run 2 the gas mixture is changed to Ar-CO2. Calculations of relevant gas properties are performed for Ar-based gas mixtures and compared to Ne-based gas mixtures to identify the most suitable Ar mixture. The drift velocity of ions in Ar is lower than in Ne. The closing time of the gating grid has to be adjusted accordingly to avoid drift field distortions due to back-drifting ions. The drift times of ions in the TPC readout chambers are calculated for the respective gas mixtures to determine the time to collect all ions from the amplification region. For LHC Run 3 the TPC readout chambers will be upgraded. The Multiwire Proportional Chambers (MWPCs) will be replaced by readout chambers based on Gas Electron Multipliers (GEMs) which are operated in continuous mode. As a consequence an ion backflow of the order of 1% causes significant space-charge distortions in the TPC drift volume. Similar distortions are expected in data taken specifically for the study of space-charge effects at the end of Run 1. The gating grid of the MWPCs is operated in the open state allowing the ions from the amplification region to enter the drift volume. The magnitude of the distortions in this data is measured and compared to the expectations for the TPC upgrade and results from current simulations.
RUCAM (Roussel Uclaf Causality Assessment Method) or its previous synonym CIOMS (Council for International Organizations of Medical Sciences) is a well established tool in common use to quantitatively assess causality in cases of suspected drug induced liver injury (DILI) and herb induced liver injury (HILI). Historical background and the original work confirm the use of RUCAM as single term for future cases, dismissing now the term CIOMS for reasons of simplicity and clarity. RUCAM represents a structured, standardized, validated, and hepatotoxicity specific diagnostic approach that attributes scores to individual key items, providing final quantitative gradings of causality for each suspect drug/herb in a case report. Experts from Europe and the United States had previously established in consensus meetings the first criteria of RUCAM to meet the requirements of clinicians and practitioners in care for their patients with suspected DILI and HILI. RUCAM was completed by additional criteria and validated, assisting to establish the timely diagnosis with a high degree of certainty. In many countries and for more than two decades, physicians, regulatory agencies, case report authors, and pharmaceutical companies successfully applied RUCAM for suspected DILI and HILI. Their practical experience, emerging new data on DILI and HILI characteristics, and few ambiguous questions in domains such alcohol use and exclusions of non-drug causes led to the present update of RUCAM. The aim was to reduce interobserver and intraobserver variability, to provide accurately defined, objective core elements, and to simplify the handling of the items. We now present the update of the well accepted original RUCAM scale and recommend its use for clinical, regulatory, publication, and expert purposes to validly establish causality in cases of suspected DILI and HILI, facilitating a straightforward application and an internationally harmonized approach of causality assessment as a common basic tool.